196 related articles for article (PubMed ID: 38688943)
1. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
Hibshman GN; Bravo JPK; Hooper MM; Dangerfield TL; Zhang H; Finkelstein IJ; Johnson KA; Taylor DW
Nat Commun; 2024 Apr; 15(1):3663. PubMed ID: 38688943
[TBL] [Abstract][Full Text] [Related]
2. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
Evans BA; Bernstein DA
mSphere; 2021 May; 6(3):. PubMed ID: 34011687
[No Abstract] [Full Text] [Related]
3. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
4. PAMless SpRY exhibits a preference for the seed region for efficient targeting.
Yang C; Zhou Z; Sun X; Ju H; Yue X; Rao S; Xue C
Cell Rep; 2024 May; 43(5):114225. PubMed ID: 38733582
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
6. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
Zhang D; Zhang B
Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
[TBL] [Abstract][Full Text] [Related]
7. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
[TBL] [Abstract][Full Text] [Related]
8. Can SpRY recognize any PAM in human cells?
Ye J; Xi H; Chen Y; Chen Q; Lu X; Lv J; Chen Y; Gu F; Zhao J
J Zhejiang Univ Sci B; 2022 May; 23(5):382-391. PubMed ID: 35557039
[TBL] [Abstract][Full Text] [Related]
9. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
Briner AE; Henriksen ED; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
[TBL] [Abstract][Full Text] [Related]
10. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
[TBL] [Abstract][Full Text] [Related]
11. The SpRY Cas9 variant release the PAM sequence constraint for genome editing in the model plant Physcomitrium patens.
Calbry J; Goudounet G; Charlot F; Guyon-Debast A; Perroud PF; Nogué F
Transgenic Res; 2024 Apr; 33(1-2):67-74. PubMed ID: 38573428
[TBL] [Abstract][Full Text] [Related]
12. PAM-less plant genome editing using a CRISPR-SpRY toolbox.
Ren Q; Sretenovic S; Liu S; Tang X; Huang L; He Y; Liu L; Guo Y; Zhong Z; Liu G; Cheng Y; Zheng X; Pan C; Yin D; Zhang Y; Li W; Qi L; Li C; Qi Y; Zhang Y
Nat Plants; 2021 Jan; 7(1):25-33. PubMed ID: 33398158
[TBL] [Abstract][Full Text] [Related]
13. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
[TBL] [Abstract][Full Text] [Related]
14. Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum.
Asano Y; Yamashita K; Hasegawa A; Ogasawara T; Iriki H; Muramoto T
Sci Rep; 2021 May; 11(1):11163. PubMed ID: 34045481
[TBL] [Abstract][Full Text] [Related]
15. Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes.
Vicencio J; Sánchez-Bolaños C; Moreno-Sánchez I; Brena D; Vejnar CE; Kukhtar D; Ruiz-López M; Cots-Ponjoan M; Rubio A; Melero NR; Crespo-Cuadrado J; Carolis C; Pérez-Pulido AJ; Giráldez AJ; Kleinstiver BP; Cerón J; Moreno-Mateos MA
Nat Commun; 2022 May; 13(1):2601. PubMed ID: 35552388
[TBL] [Abstract][Full Text] [Related]
16. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
17. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
18. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
19. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
[TBL] [Abstract][Full Text] [Related]
20. CRISPR technologies and the search for the PAM-free nuclease.
Collias D; Beisel CL
Nat Commun; 2021 Jan; 12(1):555. PubMed ID: 33483498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
